A Multicenter Pilot Study Examining the Role of Circulating Tumor Cells as a Blood-Based Tumor Marker in Patients with Extensive Small-Cell Lung Cancer

Background: Small-cell lung cancer (SCLC), a variant of lung cancer marked by early metastases, accounts for 13% of all lung cancers diagnosed in US. Despite high response rates to treatment, it is an aggressive disease with a median survival of 9–11 months for patients with extensive stage (EX-SCLC...

Full description

Saved in:
Bibliographic Details
Main Authors: Huang, Chao H., Wick, Jo A., Sittampalam, Gurusingham Sitta, Nirmalanandhan, Victor Sanjit, Ganti, Apar Kishor, Neupane, Prakash C., Williamson, Stephen K., Godwin, Andrew K., Schmitt, Sarah, Smart, Nora J., Spencer, Sarah, Van Veldhuizen, Peter J.
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2014
Subjects:
Oncology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4196518/
https://ncbi.nlm.nih.gov/pubmed/25353007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2014.00271
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items